Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro

The recent outbreak of novel coronavirus pneumonia (COVID-19) caused by a new coronavirus has posed a great threat to public health. Identifying safe and effective antivirals is of urgent demand to cure the huge number of patients. Virus-encoded proteases are considered potential drug targets. The h...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Leike, Liu, Jia, Cao, Ruiyuan, Xu, Mingyue, Wu, Yan, Shang, Weijuan, Wang, Xi, Zhang, Huanyu, Jiang, Xiaming, Sun, Yuan, Hu, Hengrui, Li, Yufeng, Zou, Gang, Zhang, Min, Zhao, Lei, Li, Wei, Guo, Xiaojia, Zhuang, Xiaomei, Yang, Xing-Lou, Shi, Zheng-Li, Deng, Fei, Hu, Zhihong, Xiao, Gengfu, Wang, Manli, Zhong, Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481761/
https://www.ncbi.nlm.nih.gov/pubmed/32910347
http://dx.doi.org/10.1007/s12250-020-00288-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481761/
https://www.ncbi.nlm.nih.gov/pubmed/32910347
http://dx.doi.org/10.1007/s12250-020-00288-1

Ejemplares similares